Title:
NOVEL USE OF IL-1β COMPOUNDS
Document Type and Number:
Japanese Patent JP2017206552
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SOLUTION: The invention discloses novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SELECTED DRAWING: None
Inventors:
LOWE PHIL
GRAM HERMANN
JUNG THOMAS
WRIGHT TIMOTHY
MUNDEL TREVOR
GRAM HERMANN
JUNG THOMAS
WRIGHT TIMOTHY
MUNDEL TREVOR
Application Number:
JP2017151327A
Publication Date:
November 24, 2017
Filing Date:
August 04, 2017
Export Citation:
Assignee:
NOVARTIS AG
International Classes:
A61K45/00; A61K39/395; A61P19/02; A61P29/00; A61P37/02; A61P43/00
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Yasuhito Suzuki
Previous Patent: A gene product distinctively revealed in a tumor, and its use
Next Patent: An oral tablet and oleophilic salt of methyl naltrexone
Next Patent: An oral tablet and oleophilic salt of methyl naltrexone